Pediatrix Medical Group (MD) Competitors

Pediatrix Medical Group (NYSE:MD) and CorVel (NASDAQ:CRVL) are both health care services companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, valuation, institutional ownership, dividends, media sentiment and earnings.

Does the media prefer MD or CRVL?

In the previous week, Pediatrix Medical Group had 5 more articles in the media than CorVel. MarketBeat recorded 10 mentions for Pediatrix Medical Group and 5 mentions for CorVel. CorVel's average media sentiment score of 0.55 beat Pediatrix Medical Group's score of 0.43 indicating that CorVel is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Pediatrix Medical Group	2 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
CorVel	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has better valuation and earnings, MD or CRVL?

CorVel has lower revenue, but higher earnings than Pediatrix Medical Group. Pediatrix Medical Group is trading at a lower price-to-earnings ratio than CorVel, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Pediatrix Medical Group	$2.01B	0.69	-$99.07M	$1.29	12.45
CorVel	$895.59M	4.09	$95.17M	$1.94	36.81

Which has more volatility and risk, MD or CRVL?

Pediatrix Medical Group has a beta of 1.26, suggesting that its stock price is 26% more volatile than the S&P 500. Comparatively, CorVel has a beta of 0.95, suggesting that its stock price is 5% less volatile than the S&P 500.

Is MD or CRVL more profitable?

CorVel has a net margin of 10.98% compared to Pediatrix Medical Group's net margin of 5.66%. CorVel's return on equity of 32.31% beat Pediatrix Medical Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Pediatrix Medical Group	5.66%	18.94%	7.10%
CorVel	10.98%	32.31%	18.33%

Do analysts prefer MD or CRVL?

Pediatrix Medical Group presently has a consensus price target of $16.79, suggesting a potential upside of 4.52%. Given Pediatrix Medical Group's stronger consensus rating and higher probable upside, analysts plainly believe Pediatrix Medical Group is more favorable than CorVel.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Pediatrix Medical Group	0 Sell rating(s)	7 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.22
CorVel	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Do institutionals & insiders hold more shares of MD or CRVL?

97.7% of Pediatrix Medical Group shares are owned by institutional investors. Comparatively, 51.4% of CorVel shares are owned by institutional investors. 0.9% of Pediatrix Medical Group shares are owned by insiders. Comparatively, 44.6% of CorVel shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

CorVel beats Pediatrix Medical Group on 9 of the 16 factors compared between the two stocks.